Literature DB >> 16446704

Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.

Maryou B K Lambros1, Pete T Simpson, Chris Jones, Rachael Natrajan, Charlotte Westbury, Dawn Steele, Kay Savage, Alan Mackay, Fernando C Schmitt, Alan Ashworth, Jorge S Reis-Filho.   

Abstract

Chromogenic (CISH) and fluorescent (FISH) in situ hybridization have emerged as reliable techniques to identify amplifications and chromosomal translocations. CISH provides a spatial distribution of gene copy number changes in tumour tissue and allows a direct correlation between copy number changes and the morphological features of neoplastic cells. However, the limited number of commercially available gene probes has hindered the use of this technique. We have devised a protocol to generate probes for CISH that can be applied to formalin-fixed, paraffin-embedded tissue sections (FFPETS). Bacterial artificial chromosomes (BACs) containing fragments of human DNA which map to specific genomic regions of interest are amplified with phi29 polymerase and random primer labelled with biotin. The genomic location of these can be readily confirmed by BAC end pair sequencing and FISH mapping on normal lymphocyte metaphase spreads. To demonstrate the reliability of the probes generated with this protocol, four strategies were employed: (i) probes mapping to cyclin D1 (CCND1) were generated and their performance was compared with that of a commercially available probe for the same gene in a series of 10 FFPETS of breast cancer samples of which five harboured CCND1 amplification; (ii) probes targeting cyclin-dependent kinase 4 were used to validate an amplification identified by microarray-based comparative genomic hybridization (aCGH) in a pleomorphic adenoma; (iii) probes targeting fibroblast growth factor receptor 1 and CCND1 were used to validate amplifications mapping to these regions, as defined by aCGH, in an invasive lobular breast carcinoma with FISH and CISH; and (iv) gene-specific probes for ETV6 and NTRK3 were used to demonstrate the presence of t(12;15)(p12;q25) translocation in a case of breast secretory carcinoma with dual colour FISH. In summary, this protocol enables the generation of probes mapping to any gene of interest that can be applied to FFPETS, allowing correlation of morphological features with gene copy number.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446704     DOI: 10.1038/labinvest.3700390

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.

Authors:  L Shan; L Ambroisine; J Clark; R J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; A Fletcher; P Flohr; S Edwards; G Attard; J De-Bono; B D Young; C S Foster; V Reuter; H Moller; T D Oliver; D M Berney; P Scardino; J Cuzick; C S Cooper; Y-J Lu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-02-23       Impact factor: 5.554

Review 2.  Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma.

Authors:  Aaron M Gruver; Ziad Peerwani; Raymond R Tubbs
Journal:  J Clin Pathol       Date:  2010-03       Impact factor: 3.411

3.  Immunophenotypic and genomic characterization of papillary carcinomas of the breast.

Authors:  Raphaëlle Duprez; Paul M Wilkerson; Magali Lacroix-Triki; Maryou B Lambros; Alan MacKay; Roger A'Hern; Arnaud Gauthier; Vidya Pawar; Pierre-Emanuel Colombo; Frances Daley; Rachael Natrajan; Eric Ward; Gaëtan MacGrogan; Flavie Arbion; Patrick Michenet; Britta Weigelt; Anne Vincent-Salomon; Jorge S Reis-Filho
Journal:  J Pathol       Date:  2011-12-09       Impact factor: 7.996

4.  c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours.

Authors:  Chris Jones; Maria Rodriguez-Pinilla; Maryou Lambros; Dorine Bax; Boo Messahel; Gordan M Vujanic; Jorge S Reis-Filho; Kathy Pritchard-Jones
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

5.  A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.

Authors:  Dorine A Bax; Alan Mackay; Suzanne E Little; Diana Carvalho; Marta Viana-Pereira; Narinder Tamber; Anita E Grigoriadis; Alan Ashworth; Rui M Reis; David W Ellison; Safa Al-Sarraj; Darren Hargrave; Chris Jones
Journal:  Clin Cancer Res       Date:  2010-06-22       Impact factor: 12.531

6.  MYC amplification in breast cancer: a chromogenic in situ hybridisation study.

Authors:  S Maria Rodriguez-Pinilla; Robin L Jones; Maryou B K Lambros; Edurne Arriola; Kay Savage; Michelle James; Sarah E Pinder; Jorge S Reis-Filho
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

7.  Whole genome sequencing of matched primary and metastatic acral melanomas.

Authors:  Samra Turajlic; Simon J Furney; Maryou B Lambros; Costas Mitsopoulos; Iwanka Kozarewa; Felipe C Geyer; Alan Mackay; Jarle Hakas; Marketa Zvelebil; Christopher J Lord; Alan Ashworth; Meirion Thomas; Gordon Stamp; James Larkin; Jorge S Reis-Filho; Richard Marais
Journal:  Genome Res       Date:  2011-12-19       Impact factor: 9.043

8.  Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.

Authors:  N Turner; M B Lambros; H M Horlings; A Pearson; R Sharpe; R Natrajan; F C Geyer; M van Kouwenhove; B Kreike; A Mackay; A Ashworth; M J van de Vijver; J S Reis-Filho
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

9.  Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.

Authors:  O Martinho; A Longatto-Filho; M B K Lambros; A Martins; C Pinheiro; A Silva; F Pardal; J Amorim; A Mackay; F Milanezi; N Tamber; K Fenwick; A Ashworth; J S Reis-Filho; J M Lopes; R M Reis
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

10.  Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.

Authors:  G Attard; J Clark; L Ambroisine; G Fisher; G Kovacs; P Flohr; D Berney; C S Foster; A Fletcher; W L Gerald; H Moller; V Reuter; J S De Bono; P Scardino; J Cuzick; C S Cooper
Journal:  Oncogene       Date:  2007-07-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.